Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 14, 2020

SELL
$10.27 - $21.23 $906,306 - $1.87 Million
-88,248 Closed
0 $0
Q4 2019

Feb 13, 2020

SELL
$8.36 - $23.81 $265,446 - $756,015
-31,752 Reduced 26.46%
88,248 $1.81 Million
Q3 2019

Nov 14, 2019

BUY
$9.83 - $14.82 $1.18 Million - $1.78 Million
120,000 New
120,000 $1.18 Million
Q4 2018

Feb 14, 2019

SELL
$19.05 - $36.45 $1.91 Million - $3.66 Million
-100,431 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$34.41 - $44.23 $3.46 Million - $4.44 Million
100,431 New
100,431 $3.73 Million

Others Institutions Holding ASMB

# of Institutions
1
Shares Held
16.3K
Call Options Held
0
Put Options Held
0

About ASSEMBLY BIOSCIENCES, INC.


  • Ticker ASMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,436,900
  • Market Cap $723M
  • Description
  • Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...
More about ASMB
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.